NCT02554630View on ClinicalTrials.gov

Novel Mechanisms and Approaches to Treat Neonatal Sepsis

CompletedOBSERVATIONAL
Enrollment

142

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

October 21, 2022

Study Completion Date

October 21, 2022

Conditions
Complication of PrematurityImmunologic Deficiency Syndromes
Interventions
OTHER

Adjuvant

Blood will be incubated, ex-vivo, with one of the adjuvant therapies or no adjuvant and then, using microfluidic techniques the immune genomic profile and the functional capacity of immune cells will be assessed.

OTHER

Blood Collection

Blood collection will be performed on all groups.

Trial Locations (1)

32610

UF Health, Gainesville

All Listed Sponsors
collaborator

National Institute of General Medical Sciences (NIGMS)

NIH

collaborator

Surgical Infection Society

UNKNOWN

lead

University of Florida

OTHER

NCT02554630 - Novel Mechanisms and Approaches to Treat Neonatal Sepsis | Biotech Hunter | Biotech Hunter